Mark Davis
Cardiovascular Disease · Midland, TXNPI 1679123475
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,370 of the $9,930 with a category attached, or 84.3%. It is spread thinly across 25 manufacturers, the largest accounting for just 23.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $3,664 and has fallen 96.7% since, to $123 in 2025.
Across 362 payments — averaging $27.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$1K
- Amarin Pharma, Inc.$1K
- Amgen$803
- GE HealthCare$661
- Novartis$594
- plus $3K from 19 others
What the payments were for
- Consulting fees$4004%
- Travel & lodging$1,15112%
- Food & beverage$8,37084%
- Education$100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 44 | $2,365 |
| Boston Scientific | 20 | $1,042 |
| Amarin Pharma, Inc. | 56 | $1,026 |
| Amgen | 48 | $803 |
| GE HealthCare | 5 | $661 |
| Novartis | 45 | $594 |
| Abiomed | 8 | $500 |
| AstraZeneca | 22 | $498 |
| Boehringer Ingelheim | 22 | $384 |
| E.r. Squibb & Sons, L.L.C. | 23 | $299 |
| Abbott | 3 | $294 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 21 | $281 |
| Edwards Lifesciences | 3 | $228 |
| Pfizer | 16 | $221 |
| Novo Nordisk | 2 | $164 |
| Teleflex Medical Canada Inc. | 1 | $146 |
| Acist Medical Systems, Inc. | 1 | $123 |
| Kowa Pharmaceuticals America, Inc. | 4 | $52 |
| Lilly USA, LLC | 4 | $48 |
| Lundbeck LLC | 3 | $45 |
| Esperion Therapeutics, Inc. | 3 | $45 |
| Merck | 3 | $39 |
| Tactile Systems Technology Inc | 2 | $30 |
| Johnson & Johnson | 2 | $25 |
| Philips North America LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CoreValve Evolut$1,155
- AVVIGO$400
- Optis Coronary Imaging System$274
- Impella$246
- GENERAL ATHERECTOMY$125
- Acist HDi$123
- BRILINTA$118
- GENERAL ULTRASOUND$117
- GENERAL - STENTS$102
How this compares
$9,930 in reported general payments places this provider in the 75th percentile of 1,515 cardiovascular disease providers in Texas.
Other cardiovascular disease in Midland
- Ramin Farzaneh-FarDallas$17.1M
- John OsborneGrapevine$1.3M
- Darren McGuireDallas$1.2M
- Peter McCulloughDallas$664K
- Ann NavarDallas$616K
- Biykem BozkurtHouston$606K
- Milton PackerDallas$530K
- Amarinder BindraDallas$512K
- Robert SalazarKingwood$478K
- Reynolds DelgadoHouston$471K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.